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A Role for 12-lipoxygenase in Nerve Cell Death
Caused by Glutathione Depletion
Yonghong Li*, Pamela Maher,² and David Schubert* of cystine, a precursor of GSH. This mechanism is exem-
plified by oxidative glutamate toxicity in neuronal cul-*Cellular Neurobiology Laboratory
tures where toxicity is initiated by the competition ofThe Salk Institute for Biological Studies
glutamate with the cystine uptake system. Glutamate²Department of Cell Biology
inhibits cystine uptake, which in turn causes a decreaseThe Scripps Research Institute
in GSH and the inability of the cell to deal with reactiveLa Jolla, California 92037
oxygen species (ROS), ultimately leading to cell death
(Murphy et al., 1989a). Oxidative glutamate toxicity is
inhibited by antioxidants such as vitamin E (Murphy etSummary
al., 1989a; Schubert et al., 1992; Mayer and Noble, 1994).
This cytotoxicity pathway is distinct from glutamate ex-An early and highly specific decrease in glutathione
citotoxicity, which is mediated by ionotropic glutamate(GSH) in thesubstantia nigra is associated with Parkin-
receptors.son's disease, and low levels of GSH lead to the degen-
Neuronal cell death via the oxidative pathway haseration of cultured dopaminergic neurons. Using im-
many of the characteristics of apoptosis, includingmature cortical neurons and a clonal nerve cell line,
nuclear condensation and cleavage of chromatin intoit is shown that a decrease in GSH triggers the activa-
oligonucleosomal fragments (Ratan et al., 1994b). Celltion of neuronal 12-lipoxygenase (12-LOX), which
death depends on macromolecular synthesis (Ratan etleads to the production of peroxides, the influx of Ca21,
al., 1994a, 1994b). The overexpression of bcl-2 (Behl etand ultimately to cell death. The supporting evidence
al., 1993) or the activation of protein kinase C (Davisincludes: 1) inhibitors of arachidonate metabolism and
and Maher, 1994) prevents cell death. Growth factors12-LOX block cell death induced by GSH depletion; 2)
such as epidermal growth factor also attenuate oxida-there is an increase in 12-LOX activity and a membrane
tive glutamate toxicity (Schubert et al., 1992). However,translocation in HT22 cells, and an induction of the
the signaling pathways that mediate oxidative glutamateenzyme in primary cortical neurons following the re-
toxicity remain largely unknown.duction of GSH; 3) 12-LOX is directly inhibited by GSH;
A number of biochemical pathways participate in theand 4) exogenous arachidonic acid potentiates cell
regulation of apoptosis (reviewed by Hale et al., 1996;death. These data show that the LOX pathway is a
McConkey and Orrenius, 1994). The sphingolipid metab-critical intermediate in at least some forms of neuronal
olite ceramide mediates apoptosis in response to a vari-degeneration.
ety of stimuli including tumor necrosis factor a and the
Fas ligand (reviewed by Hannun, 1996). There is also
recent evidence that other lipid metabolites, such as
Introduction arachidonic acid±derived eicosanoids, may play a role
in regulating cell survival (Korystov et al., 1996; Tang et
While physiologically programmed cell death (PCD) al., 1996). Down-regulation of arachidonate lipoxygen-
functions in the normal development of the nervous sys- ase (LOX) results in apoptosis in a carcinosarcoma cell
tem, inappropriate PCD leads to the neuronal loss asso- line (Tang et al., 1996), while irradiation-induced thymo-
ciated with various neuropathological disorders such as cyte apoptosis appears to be mediated by LOX metabo-
Alzheimer's disease (Su et al., 1994; Smale et al., 1995) lites (Korystov et al., 1996). Although the mechanisms
and Parkinson's disease (PD) (Mochizuki et al., 1996). by which arachidonic acid metabolites influence cell
PCD in Alzheimer's disease and PD is thought to be growth or survival are not known, arachidonic acid can
linked to oxidative stress, for excessive lipid and protein activate several signaling pathways directly by itself or
oxidation occurs and cellular antioxidant systems are by its metabolites through LOX, cyclooxygenase, or cy-
altered (reviewed by Jenner and Olanow, 1996; Simonian tochrome P450 pathways (reviewed by Shimizu and
and Coyle, 1996). In the substantia nigra of PD patients, Wolfe, 1990).
there is an early and highly specific decrease in glutathi- LOXs are dioxygenases that incorporate molecular
one (GSH) (Perry et al., 1982; Sofic et al., 1992; Sian et oxygen into specific positions of polyunsaturated fatty
al., 1994), which may precede cell death (Dexter et al., acids and, based on the site of insertion of the oxygen,
1994). In addition, the blocking of GSH synthesis by are generally classified as 5-, 12-, or 15-LOXs (Shimizu
buthionine sulfoximine (BSO), an inhibitor of g-glutamyl- and Wolfe, 1990). 12-LOX is the predominant LOX in the
cysteine synthetase, the rate-limiting synthetic step in brain, and its mRNA is present in rat cortical neurons,
GSH synthesis, results in the degeneration of cultured oligodendrocytes, and astrocytes (Bendani et al., 1995).
dopaminergic neurons (Jenner and Olanow, 1996). BSO Cloned rat brain 12-LOX generates predominately
also potentiates the toxicity to dopaminergic neurons 12-hydroxyeicosatetraenoic acid (12-HETE) and also
of 6-hydroxydopamine, MPTP, and MPP1 (Pileblad et some 15-hydroxyeicosatetraenoic acid (15-HETE) (Wa-
al., 1989; Wullner et al., 1996). These observations sug- tanabe et al., 1993). 12-HETE and its derivatives are the
gest a pivotal role for GSH in the pathogenesis of PD major metabolites of LOXs in the brain (Sautebin et al.,
(Jenner and Olanow, 1996). 1978; Shimizu et al., 1987). These metabolites may play
In addition to g-glutamylcysteine synthetase activity, an important role as second messengers in synaptic
transmission and as retrograde messengers in learningthe synthesis of GSH can be regulated by the transport
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and memory (reviewed by Piomelli, 1994; Shimizu and glutamate toxicity was seen (Figure 1B). The epoxygen-
ase inhibitor metyropane also did not protect at dosesWolfe, 1990). They may also contribute to neuropatho-
logical events such as brain ischemia (Shimizu and up to 1 mM (Figure 1B). Therefore, LOX enzymatic activ-
ity plays a role in glutamate toxicity.Wolfe, 1990).
Several observations suggest that 12-LOX may play Since there are several forms of LOX (Shimizu and
Wolfe, 1990), selective inhibitors of 5- and 12-LOXs werea role in oxidative glutamate toxicity. First, there is an
early reduction in GSH levels in oxidative glutamate tox- used to determine the specific LOX required for gluta-
mate toxicity. Two selective inhibitors of 12-LOX, baical-icity (Murphy et al., 1989b), and decreased GSH can
trigger theactivation of 12-LOX (Shornick and Holtzman, ein (5, 6, 7-trihydroxyflavone) (Sekiya and Okuda, 1982)
and cinnamyl-3, 4-dihydroxy-a-cyanocinnamide (CDC)1993; Hagmann et al., 1993). Second, peroxides are pro-
duced in oxidative glutamate toxicity (Maher and Davis, (Cho et al., 1991), both conferred full protection from
glutamate toxicity (Figure 1C). Three selective inhibitors1996), and peroxides induce the expression of c-Jun
and c-Fos, which have been implicated in neuronal of 5-LOX were also tested, and two of them, caffeic acid
(Koshihara et al., 1984) and 5, 6-dehydro-arachidonicapoptosis throughLOX pathways (Rao et al., 1993). Last,
the activation of soluble guanylate cyclase via an NO- acid (DAA) (Sok et al., 1982), were not protective at any
dose (Figure 1C, and data not shown). However, anotherindependent pathway is required for cell death in oxida-
tive glutamate toxicity (Li et al., unpublished data), and 5-LOX inhibitor, 2, 3, 5-trimethyl-6-(12-hydroxy-5±10-
dodecadiynyl)-1, 4-benzoquinone (AA861) (Yoshimoto etarachidonate metabolites are activators of guanylate
cyclase (Snider et al., 1984). al., 1982), protected cells (Figure 1C). Although widely
used as a 5-LOX inhibitor, AA861 also inhibits leukocyteIn this paper, evidence is presented for a requirement
of 12-LOX in oxidative glutamate toxicity, and it is 12-LOX (Yoshimoto et al., 1982). In view of the minimal
effect of the other two inhibitors of 5-LOX and the simi-shown that glutamate-induced GSH depletion activates
12-LOX. The role of 12-LOX in linking GSH depletion to larity of brain 12-LOX to leukocyte 12-LOX (71% iden-
tity), the effect of AA861 is probably due to its inhibitionneuronal cell death is then demonstrated by establishing
that BSO-induced cell death also requires 12-LOX activ- of 12-LOX. These results suggest that 12-LOX, the pre-
dominant brain isoform of this enzyme, is involved inity. Finally, it is shown that 12-LOX is a prerequisite for
the Ca21 influx and peroxide production. the pathway leading to oxidative glutamate toxicity.
Inhibitors of LOX Also Block the OxidativeResults
Glutamate Toxicity in Primary
Cortical NeuronsInhibitors of Arachidonate Metabolism Block
To determine whether the observations with the HT22Oxidative Glutamate Toxicity
cells reflect the mechanism of oxidative glutamateHT22 is a hippocampal nerve cell line that isvery suscep-
toxicity in the brain, embryonic rat cortical neurons weretible to oxidative stress caused by exposure to gluta-
prepared, and 1 day later, the cells were exposed tomate. The addition of 5 mM glutamate to the growth
glutamate. These young cultures are devoid of func-medium results in cell lysis, which is initiated at 8 hr and
tional glutamate receptors and are killed by glutamate-is complete by 16 hr (Davis and Maher, 1994; Maher
induced oxidative stress via an apoptotic pathway (Mur-and Davis, 1996). Loss of cell viability was quantitated
phy and Baraban, 1990; Murphy et al., 1990; Ratan etby the decrease in the ability of cells exposed to gluta-
al., 1994b). A 24 hr exposure to 5 mM glutamate resultedmate to metabolize the dye 3-(4,5-dimethyldiazol-2-yl)-
in the disappearance of neurites and the shrinkage of2,5-diphenyl tetrazolium bromide (MTT) (Mosmann,
cell bodies (Figures 2A and 2B). The 12-LOX inhibitor1983), compared to control (Figure 1A). In this system,
baicalein almost completely rescued the cells from glu-the MTT is a direct measure of cell death since it corre-
tamate toxicity (Figure 2C). Other LOX inhibitors capablelates with trypan blue and colony formation viability
of protecting HT22 cells also blocked glutamate-assays (Davis and Maher, 1994). Because of its potential
induced cell death of cortical cells in a dose-dependentrole in PCD, it was asked whether inhibitors of arachido-
manner (Figure 1D). It was not possible to demonstratenate metabolism alter toxicity. Figure 1A shows that
an effect of ETYA on glutamate toxicity in primary cellsglutamate toxicity was reduced in a dose-dependent
since ETYA is very toxic to these cells. Consistent withmanner by 5, 8, 11, 14-eicosatetraynoic acid (ETYA), a
the findings using HT22 cells, the 5-LOX inhibitors caf-competitive analog of arachidonic acid, suggesting that
feic acid and DAA could not prevent glutamate-inducedarachidonic acid is involved in glutamate toxicity.
cell death in primary cortical cultures (Figure 1D, andTo determine which metabolites of arachidonic acid
data not shown).are involved in glutamate toxicity, inhibitors of oxy-
genases that use arachidonic acid as substrates were
tested for theirability to reduce toxicity. Nordihydroguai- Glutamate Activates 12-LOX and Causes
Translocation to the Membrane in HT22aretic acid (NDGA), a general LOX inhibitor, protected
HT22 cells from glutamate toxicity (Figure 1B; see also, Cells, but Induces the Enzyme
in Primary NeuronsMurphy et al., 1989b). The concentration required for
maximal protection was 0.5±1.0 mM. NDGA was toxic The observation that 12-LOX inhibitors block glutamate
toxicity suggests that this enzyme is a necessary stepto cells at concentrations .5 mM (data not shown). In
contrast, when indomethacin, a specific inhibitor of in the signaling pathway leading to cell death. LOX may
simply be required in this pathway or it may be a limitingcyclooxygenase with an IC50 of 1 mM, was tested at
concentrations up to 100 mM, no protective effect on factor and demand activation during the cell death
12-lipoxygenase Mediates Neuronal Cell Death
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Figure 1. LOX Inhibitors Block Glutamate Toxicity
(A) Dose effect of the arachidonic acid analog. HT22 cells were seeded onto 96-well microtiter plates at 2.5 3 103 cells per well and the next
day were treated with ETYA at the concentrations indicated 10 min before the addition of 5 mM glutamate. After 20 hr, the cell viability was
determined by the MTT assay and confirmed by visual inspection. The MTT assay is, in this system, directly proportional to viable cell number
(Davis and Maher, 1994). Results are expressed relative to controls with agents alone. The effect of the agents on dye reduction in the absence
of cells, if any, was adjusted by subtracting the value for the medium control. The results shown are the mean 6 SD of a typical experiment
with five determinations. Similar results were obtained in three independent experiments. *, significantly different from glutamate treatment
alone (P , 0.005, Student's t-test). The following experiments were subject to the same analysis described above unless otherwise stated.
(B) Dose effect of the LOX inhibitor NDGA, the cyclooxygenase inhibitor indomethacin (Ind), and the epoxygenase inhibitor metyropane (Met).
The concentrations given for each inhibitor are in micromolars. The control did not receive glutamate.
(C) Dose effect of the 12-LOX inhibitors baicalein (Bai) and CDC and the 5-LOX inhibitors caffeic acid (CA), DAA, and AA861. The concentrations
given for each inhibitor are in micromolars. The control did not receive glutamate.
(D) Dose effect of various LOX inhibitors in primary cortical neurons. Experiments were performed similarly to those described above except
that 5 3 104 cells were seeded to each well of a 96-well plate. The concentrations given for each inhibitor are in micromolars. Error bars that
are not visible are less than the width of the symbol.
process. Three assays were done to determine whether the rate of exogenous arachidonic acid uptake was de-
termined as a function of time following glutamate ex-there is increased LOX activity following exposure to
glutamate. LOX enzymatic activity was measured in a posure. Figures 3A and 3B show that all three assays
indicate an increase in arachidonic acid metabolism be-cell-free system, the expression and the translocation
of LOX enzyme to the membrane were examined, and tween 4 and 8 hr after glutamate exposure in HT22 cells.
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by translocation to the membrane (Baba et al., 1989;
Hagmann et al., 1993). Figure 3B shows that while there
is no overall increase in the level of LOX protein in HT22
cells, which suggests that 12-LOX is constitutively ex-
pressed, there is a translocation of the larger form of
the enzyme to the membrane fraction. Unlike HT22 cells,
glutamate induces a 2- to 3-fold increase in 12-LOX
protein in primary cortical neurons (Figure 3C). 12-LOX
consists of two forms of about 76 kDa and 78 kDa. The
same doublet pattern is also observed when lysates of
HEK293 cells transfected with murine leukocyte-type
12-LOX are probed with the antibody used in our experi-
ments (Kinzig et al., 1997).
The above experiments suggest that arachidonic acid
may, in part, be limiting LOX activity in the presence of
glutamate. If so, then arachidonic acid should potentiate
glutamate toxicity. Exogenously added arachidonic acid
indeed potentiated glutamate toxicity in a dose-depen-
dent manner (Figure 4A). The potentiation effect was
seen at a concentration as low as 2 mM, while arachi-
donic acid alone was not toxic at concentrations used.
Activation of 12-LOX Follows GSH Depletion
The activation of 12-LOX could be by increased sub-
strate availability, the loss of an inhibitor, through a sec-
ondary activator, by increased enzyme synthesis, or by
a combination of these factors. The above data show
that there is no increase in LOX enzyme (Figure 3B) and
that arachidonic acid is rate limiting in the presence
of glutamate (Figures 3A and 4A). Since GSH directly
inhibits LOX (Shornick and Holtzman, 1993; Hagmann
et al., 1993), the temporal relationship between GSH
concentration and LOX activity was examined. The ex-
posure of HT22 cells to glutamate induces a depletion
of intracellular GSH. Figure 3A shows that GSH drops
to an almost undetectable level by 6 hr after the addition
of 5 mM glutamate, which coincides with the observed
increase in LOX activity and arachidonic acid uptake.
LOX inhibitors did not alter the depletion of GSH (Figure
3A, and data not shown), suggesting that LOX acts
downstream of GSH depletion. Glutamate also causes
GSH depletion in primary cortical neurons (Figure 3C).
To determine whether the 12-LOX activity in HT22 cells
is regulated by GSH as with other cells, the effect of
GSH on 12-LOX enzymatic activity was examined in
lysates of HT22 cells treated with 5 mM Glu for 8 hr, at
which time GSH has fallen to an undetectable level (Fig-
ure 3A). The formation of 12-HETE by 12-LOX was inhib-
ited by increased GSH, with a half maximal inhibition of
Figure 2. LOX Inhibitors Block Glutamate Toxicity in Rat Cortical z1 mM (Figure 5). This is well within the normal range
Neurons
of intracellular GSH (Halliwell and Gutteridge, 1989).
(A±C) Phase contrast images of immature cortical neurons mock
treated (A), treated with 5 mM glutamate (B), or treated with 5 mM
glutamate and 1.5 mM baicalein (C). One-day-old primary cultures Depletion of GSH by BSO Induces Cell Death,
prepared from embryonic day 17 rats were treated as described Which Is Prevented by LOX Inhibitors
and photographed 24 hr later. Scale bar 5 25 mM.
If thedecreased levelof GSHcaused by glutamate expo-
sure is the activator of 12-LOX and LOX-dependent cell
death in HT22 cells, then decreasing GSH by methodsThere is an increase in arachidonic acid uptake, and a
2- to 5-fold increase in the rate of 12-HETE formation independent of glutamate should also lead to a toxic
response, which is inhibited by LOX inhibitors. BSO isin cell lysates (Figure 3A). LOX product formation and
arachidonate uptake were blocked by NDGA and baical- an inhibitor of g-glutamylcysteine synthetase, the rate-
limiting enzyme in GSH biosynthesis. Exposure of HT22ein at concentrations that inhibit glutamate toxicity (data
not shown). LOX activation is frequently accompanied cells to BSO reduces cellular GSH levels and causes
12-lipoxygenase Mediates Neuronal Cell Death
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cell death in a dose-dependent fashion (Figure 6A).
Treatment of cells with 30 mM BSO for 20 hr resulted in
total cell lysis. The toxicity of BSO was blocked by the
arachidonic acid analog ETYA and other LOX inhibitors
at concentrations similar to those that block glutamate
toxicity (Figure 6B). BSO also depletes intracellular GSH
and is toxic to primary cortical neurons (Figure 6A), and
the toxicity is blocked by LOX inhibitors (data not
shown). As with glutamate toxicity, arachidonic acid po-
tentiates BSO toxicity, showing that the effect of arachi-
donic acid is not on amino acid transport (Figure 4B).
These data suggest that 12-LOX activity is required for
neuronal cell death due to GSH depletion independently
of the mechanism of oxidative toxicity.
12-LOX Is Required for Ca21 Influx
Ca21 influx is required for oxidative glutamate toxicity,
for 50 mM cobalt or Ca21 depleted media block toxicity
(Murphy et al., 1989a; Davis and Maher, 1994). Because
in clonal cells 12-HETE can regulate ion channels (Stern
et al., 1993), we asked whether 12-LOX activity is a
prerequisite for the Ca21 influx, whichprecedes cell lysis.
The effect of LOX inhibitors on the level of intracellular
Ca21 following glutamate treatment was therefore exam-
ined. The intracellular Ca21 response to glutamate was
determined by flow cytometry using a ratiometric analy-
sis with Indo-1 (June and Rabinovitch, 1991). The bind-
ing of Ca21 to the fluorescent dye Indo-1 results in a
spectral shift in Indo-1 excitation wavelength from 380±
340 nm. The ratio of fluorescence intensities from the
two emission peaks is proportional to the Ca21 concen-
tration (Grynkiewicz et al., 1985). HT22 cells were mock
treated or treated with 5 mM glutamate in the presence
or absence of LOX inhibitors for 12 hr, loaded with
Indo-1, and Ca21 influx was measured. Figure 7A shows
that treatment with 5 mM glutamate for 12 hr resulted
in a dramatic increase in overall Ca21 levels. The rise of
Ca21 was prevented by the LOX inhibitors baicalein,
NDGA, CDC, and AA861 as well as the arachidonic acid
analog ETYA (Figure 7A). These inhibitors had no effect
on Ca21 levels in control cells (data not shown). Neither
relative to controls at 0 hr. Results for GSH are the mean 6 SD of
a typical experiment with three determinations. The level of GSH
for the untreated control cells was 21.8 6 1.4 nmol/mg protein and
that of control 12-LOX activity was 0.11 6 0.05 nmol/mg/15 min
(n 5 7). Results for 12-LOX activity and the rate of arachidonic acid
uptake are the mean 6 SD of four independent experiments.
(B) Equal amounts of total cell lysates (5 mg) or the membrane
fraction (3.5 mg) from cells exposed to 5 mM glutamate for various
times (hr) indicated above each lane were resolved in 10% SDS±
polyacrylamide gels and transferred to a nitrocellulose. The nitrocel-
lulose was probed with antiserum to human 12-LOX, HRP-conju-
gated secondary antibody,and developed with chemiluminescence.
12-LOX runs as a doublet of about 76 and 78 kDa (arrowheads).
Figure 3. Time Course Analysis of GSH Levels, 12-LOX Activity, the The protein molecular weights are given in kDa at the left.
Rate of Arachidonic Acid (AA) Uptake, and 12-LOX Expression and (C) Time course analysis of GSH and 12-LOX in primary cortical
Translocation Following Glutamate Exposure neurons following glutamate treatment. Experiments were per-
(A) HT22 cells were treated with 5 mM glutamate alone or with 10 formed as described above. Insert, a representative Western blot
mM baicalein (Bai) for various times and collected for the assay of of 12-LOX induction in primary cultures. The Western blots were
GSH and 12-LOX activity as described in the Experimental Proce- quantitated (n 5 3), andthe resultswere expressed relative to control
dures. The rate of arachidonic acid uptake was determined by pulse- levels. Equal loading of protein (5 mg/lane) was verified by staining
labeling cells for 1 hr with 3H-arachidonic acid followed by analysis and with an anti-actin antibody. Error bars that are not visible are
as described in the Experimental Procedures. Data are expressed less than the width of the symbol.
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Figure 5. The GSH Concentration Regulates Neuronal 12-LOX
Activity
Cell lysates of HT22 cells treated with 5 mM glutamate for 8 hr were
used for an in vitro enzymatic assay for 12-LOX activity as described
in the Experimental Procedures. GSH was added to the reaction
mixtures at the indicated concentrations. 12-LOX activity, ex-
pressed as relative to controls without addition of GSH, is shown
as the mean 6 SD (n 5 6).
cell death. Older cultures express ionotropic glutamate
receptors, precluding these experiments.
12-LOX Activity Is Required
for Peroxide Production
Peroxide formation is a necessary intermediate in oxida-
tive glutamate toxicity (Davis and Maher, 1994; Maher
and Davis, 1996). To determine whether LOX activation
is required for peroxide formation, the effect of LOX
inhibitors on the formation of peroxide was examined
by flow cytometry using 29,79-dichlorofluorescin diace-
tate as a probe. The nonfluorescent dye 29,79-dichloro-
fluorescin diacetate is deacetylated by intracellular es-
terases after crossing cell membranes to give rise to
dichlorofluorescin. The latter is trapped within cells and
oxidized to the fluorescent compound dichlorofluores-
cein by peroxides (Royall and Ischiropoulos, 1993).
Treatment of cells with 5 mM glutamate results in a
dramatic increase in the level of peroxides (Figures 7BFigure 4. Exogenously Added Arachidonic Acid Potentiates Cell
and 7C). The increase in the peroxide level was almostDeath Induced by Glutamate (A) or BSO (B)
totally inhibited by treatment of cells with baicalein (Fig-Experiments and data analysis were performed as described in the
legends to Figure 1 or Figure 6, except that the HT22 cells were ures 7B and 7C), at a concentration that conferred full
treated with glutamate or BSO and/or with arachidonic acid at the protection from glutamate toxicity (Figure 1). Other in-
concentrations indicated. hibitors of arachidonic acid metabolism and 12-LOX (but
(A) Results are expressed relative to control without any treatment.
not 5-LOX) also reduced the accumulation of peroxidesNote that arachidonic acid has no significant effect on cell growth
following treatment with glutamate (data not shown).at or under 50 mM (compare cell viabilities at 0 mM glutamate).
Therefore, 12-LOX activation precedes peroxide pro-(B) Results are expressed relative to controls with agents alone.
Repeated three times with similar results. duction during oxidative glutamate toxicity.
Discussion
caffeic acid nor DAA, which could not block glutamate
toxicity, could prevent the rise of Ca21 (data not shown). The above experiments demonstrate that 12-LOX is in-
volved in the pathway of neuronal cell death, which isIt follows that 12-LOX activity is required for the Ca21
influx. Similar experiments were not possible with pri- initiated by GSH depletion. This conclusion is based on
the following data: 1) inhibitors of arachidonate metabo-mary cultures because intracellular calcium is not stabi-
lized in young cultures where there is still spontaneous lism and of 12-LOX prevent cell death (Figures 1 and 2);
12-lipoxygenase Mediates Neuronal Cell Death
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2) the activity of 12-LOX is increased following glutamate
exposure, and there is a shift of one LOX isoform from
the cytoplasm to the plasma membrane in HT22 and
increased enzyme production inprimary cultures (Figure
3); and 3) exogenously added arachidonic acid potenti-
ates cell death (Figure 4). Since the metabolism of ara-
chidonic acid by 12-LOX yields a number of eicosanoids
(Shimizu and Wolfe, 1990), it is likely that one or more
of these, which remain to be identified, play critical roles
in the induction of the neuronal cell death via the oxida-
tive pathway.
Despite being the major LOX isoform in the brain (Sau-
tebin et al., 1978; Shimizu et al., 1987), the biological
roles of 12-LOX have not been well characterized. How-
ever, arachidonic acid metabolism has been implicated
in neuronal function (see, for example, Murphy et al.,
1989b; Shimizu and Wolfe, 1990; Piomelli, 1994). 12-LOX
metabolites are messengers for FMRFamide (Phe-Met-
Arg-Phe amide, a molluscan peptide) induced hyperpo-
larization in Aplysia sensory neurons (Piomelli et al.,
1987; Buttner et al., 1989), and the activation of the
NMDA receptor causes an increase in Ca21 influx and
a subsequent release of arachidonic acid (Dumuis et al.,
1988, 1993). In contrast, the above data show that the
metabolism of arachidonic acid is increased by gluta-
mate (Figure 3) and that Ca21 influx is downstream of
the requirement for 12-LOX (Figure 7A).
Although a variety of potential mechanisms may acti-
vate 12-LOX in the neuronal cell death pathway, it is
likely that the enzyme is initially activated by GSH deple-
tion. This is supported by the following experiments: 1)
the time course analysis, which shows that increased
12-LOX activity follows the depletion of GSH (Figure 3A);
2) the in vitro enzymatic assay, which shows that an
increase in the GSH concentration inhibits 12-LOX activ-
ity (Figure 5); and 3) the artificial depletion of GSH by
BSO, which activates a LOX-dependent cell death path-
way that is indistinguishable from that of glutamate tox-
icity (Figure 6). The regulation of 12-LOX activity by GSH
has also been demonstrated in several other systems
(Shornick and Holtzman, 1993; Hagmann et al., 1993).
The data presented above are summarized in the fol-
lowing model of GSH depletion-induced neuronal cell
death. Competition of cysteine uptake by glutamate or
direct inhibition of a GSH-synthesis enzyme by BSO
results in the depletion of intracellular GSH, which then
triggers the activation of 12-LOX and therefore an
increased production of 12-LOX metabolites such as
12-HETE. The activation of 12-LOX is an event upstream
of Ca21 influx and ROS production in HT22 cells. Al-
Figure 6. BSO Depletes Intracellular GSH and Induces Cell Death, though LOX activation is also upstream of ROS produc-
Which Is Prevented by LOX Inhibitors
tion in primary cultures and is required for cell death, it
(A) Dose effect of BSO on intracellular GSH levels and cell viability.
HT22 cells or primary cortical neurons were grown in DMEM con-
taining 5% horse serum and treated with BSO at the concentrations
indicated. Horse serum was used instead of FBS because the sensi-
tivity of HT22 cells to BSO was much lower and more variable when determined by the MTT assay at 20 hr after the treatment. Similar
cells were grown in FBS. BSO solutions were prepared just prior to results were obtained in three independent experiments.
use. GSH levels were measured as described in the Experimental (B) Dose effect of LOX inhibitors on BSO toxicity. HT22 cells were
Procedures at 12 hr after treatment. Results for GSH are the mean treated with LOX inhibitors at the concentrations indicated (micro-
6 SD of a typical experiment with three determinations and ex- molars) for 1 hr followed by treatment with BSO at 30 mM for 20 hr.
pressed as the percentage of controls. Error bars that are not visible Cell viability was determined by the MTT assay and is expressed
are less than the width of the symbol. The basal level of GSH was as the percentage of control. The experiment was repeated three
21.8 6 1.4 and 10.1 6 0.5 nmol/mg protein for the untreated HT22 times with similar results. *, significantly different from BSO treat-
cells and primary cortical neurons, respectively. Cell viability was ment alone (P , 0.005, Student's t-test).
Neuron
460
Figure 7. Inhibition of LOX Prevents Gluta-
mate-Induced Ca21 Influx and Peroxide Pro-
duction
(A) HT22 cells were mock treated or treated
with 5 mM glutamate in the absence or pres-
ence of other reagents for 12 hr; loaded with
Indo-1 for 30 min; and the fluorescence from
the two emission peaks of Indo-1, 410 nm
(FL32) and 485 nm (FL4), was collected, and
the ratio of the FL32 to FL4 was obtained.
Scatter plots displaying the side angel scatter
(SSC-height, which is proportional to the
gravity of cells) versus the FL32:FL4 ratio of
intracellular indo-1 emitted fluorescence
(proportional to Ca21) were transferred to an
Adobe Photoshop program and combined
(SSC-height on the x-axis is not marked).
Each plot represents a total of 10,000 viable
cells. Similar results were obtained in three
independent experiments, each with two re-
peated samples. The concentrations of LOX
inhibitors were 20 mM for ETYA, 1 mM for
NDGA, 10 mM for Bai, 15 mM for CDC, and
1 mM for AA861. Control, no glutamate
treatment.
(B) Experiments were performed in HT22 cells
as above except that intracellular peroxide
level was measured by FACS analysis de-
scribed in the Experimental Procedures. A
typical set of histograms showing cell counts
versus DCF fluorescence are presented. Re-
sults were from 10,000 viable cells. The rela-
tive medium fluorescences (RMF) are given
for each histogram. Control, no treatment;
glutamate, 5 mM; baicalein, 10 mM. Similar
results were obtained in two independent ex-
periments.
(C) Experiments were performed as in (B) ex-
cept that primary cortical neurons were used.
Baicalein was used at 1.5 mM.
has not been formally established that it is upstream of In conclusion, our studies establish a role for 12-LOX
calcium influx in that system. This model predicts that in coupling neuronal cell death to GSH depletion. These
the activation of 12-LOX by other means will also con- findings underscore the significance of the early loss of
tribute to neuronal cell death. GSH observed inPD and furtherstrengthen the oxidative
The cascade linking GSH depletion, 12-LOX activa- stress hypothesis for the pathogenesis of PD. An early
tion, and neuronal cell death has implications in neuro- loss of GSH in PD may initiate a series of events, includ-
pathological conditions such as PD. GSH plays a central ing the activation of 12-LOX, leading to the production
role in the GSH peroxidase±mediated breakdown of of ROS. The loss of GSH also renders cells unable to
H2O2 and organic peroxides, thus protecting cells from efficiently remove the ROS even though the levels of
oxidative damage (Meister and Anderson, 1983). In PD, GSH peroxidase are normal. The observation of a causal
a marked nigral GSH depletion occurs primarily in non- role for GSH depletion in the production of ROS sug-
neuronal cells, yet the majority of the cell death occurs gests that an early correction of intracellular GSH con-
in neurons. A role for GSH depletion in regulating 12-LOX centration in PD warrants consideration as a therapeutic
activity as shown in this study may help to resolve the approach to the disease.
above discrepancy, since 12-LOX is also abundant in
neuroglial cells (Bendani et al., 1995). Eicosanoids such
Experimental Procedures
as 12-HETE are membrane permeable (but GSH is not)
and can act as extracellular messengers. Therefore, HT22 Cell Culture and Toxicity Studies
GSH depletion and LOX activation in glia may generate The HT22 nerve cell line is a subclone of HT4 (Morimoto and Kosh-
land, 1989), which was derived from the mouse hippocampus. The12-LOX metabolites, which can act on nerve cells. Neu-
HT22 clone was selected for its sensitivity to glutamate toxicity. Theronal cells may be more susceptible to 12-LOX metabo-
cells do not possess active ionotropic glutamate receptors and arelites than non-neuronal cells, and 12-LOX metabolites
not subject to excitotoxicity (Maher and Davis, 1996). HT22 cellsreleased from neuroglial cells may initiate or potentiate
were propagated in Dulbecco's Modified Eagle Medium (DMEM;
neuronal cell death. A potential target for 12-LOX metab- Vogt and Dulbecco, 1963) supplemented with 10% fetal bovine se-
olites is Ca21 channels (Stern et al., 1993), and the above rum (FBS). Cell survival was determined by the MTT assay as de-
experiments and data to be presented elsewhere show scribed (Schubert and Behl, 1993), which in this cell system corre-
lates with cell death as determined by trypan blue exclusion and athat LOX metabolites indirectly activate Ca21 influx.
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colony-forming assay (Davis and Maher, 1994). Briefly, HT22 cells goat anti-rabbit immunoglobulin G secondary antibody at a dilution
of 1:20,000. The antibody conjugates were detected using a chemi-are dissociated with pancreatin (GIBCO/BRL, Bethesda, MD) and
seeded onto 96-well microtiter plates in 5% dialyzed FBS at a den- luminescence Western blot kit (Amersham, Buckinghamshire, En-
gland).sity of 2.5 3 103 cells per well in 100 ml medium. The next day, cells
are treated with various reagents according to the experimental
design and 5 mM glutamate. Twenty hours after the addition of Ca21 Measurement
glutamate, 10 ml of the MTT solution (5 mg/ml) is added to each The intracellular ionized calcium concentration was determined us-
well and incubated for 4 hr. Solubilization solution (100 ml: 50% ing Indo-1 acetoxymethylester and ratiometric analysis through flow
dimethylfomamide, 20% SDS [pH 4.8]) is then added to the wells, cytometry. HT22 cells were treated for a specific time and loaded
and the next day, the absorption values at 570 nm are measured. with 1 mM Indo-1 in the presence of 0.005% Pluronic F-127 by
The results are expressed relative to the controls specified in each adding the dye to the loading medium (DMEM plus 10% fetal calf
experiment, and were subjected to statistical analysis (Student's serum). After an incubation of 30 min at 378C, cells were then col-
t-test). lected, washed, and resuspended in room temperature phenol red-
free HEPES buffered DMEM supplemented with 2% dialyzed FBS
and 7 mM propidium iodide to determine cell viability. Cells werePrimary Cortical Culture and Toxicity Studies
allowed a 15 min recovery period to hydrolyze the ester bond beforePrimary cortical neurons were prepared from embryonic day 17
being analyzed with a FACStarplus flow cytometer (Becton Dickin-Sprague-Dawley rats as described (Abe et al., 1990). Cells were
son). The fluorescence from the two emission peaks of Indo-1, 410dissociated from the cortex and maintained in minimal essential
nm (FL32) and 485 nm (FL4), was collected, and the ratio of themedium supplemented with 30 mM glucose, 2 mM glutamine, 1 mM
FL32 to FL4 was obtained. Ca21 concentration is proportional topyruvate, and 10% fetal calf serum. For toxicity studies, cells were
the ratio of FL32 to FL4 (Grynkiewicz et al., 1985), which was pre-plated on polylysine-coated 96-well microtiter dishes at 50,000
sented at arbitrary units. Each assay was based on the analysis ofcells/100 ml in each well and subjected to the described treatments
10,000 viable cells.24 hr after the initial plating. The effect of various reagents on gluta-
mate toxicity was determined by the MTT assay and also assessed
Peroxide Measurementvisually through cell counting. Results are expressed relative to the
Intracellular peroxide levels were measured by the flow cytometriccontrols treated with reagents alone.
method (Royall and Ischiropoulos, 1993). Briefly, HT22 cells were
seeded at a density of 0.5 3 106 and primary neurons at 5 3 106LOX Assays
cells/100 mm dish and, 12 hr later, were either mock treated orLOX activity was measured in cell lysates by the methodof Natarajan
treated with 5 mM glutamate and other reagents. After another 12 hr,et al. (1993). Briefly, cell lysates were prepared in 25 mM Tris±HCl
cells were dissociated from plates by incubating in 5 ml pancreatic(pH 7.7). The reaction was initiated by the addition of 10 mM arachi-
solution. 29,79-dichlorofluorescin diacetate (10 mM) was added dur-donic acid together with 2 mCi/ml [3H] arachidonate (New England
ing cell dissociation for 10 min. Cells were then collected, washed,Nuclear, Boston). After 15 min at 378C, the reaction mix was ex-
and resuspended in room temperature phenol red-free HEPES buf-tracted and analyzed for 12 [3H]-HETE by reverse phase high pres-
fered DMEM supplemented with 2% dialyzed FBS. We found thatsure liquid chromatography (Shornick and Holtzman, 1993). The
washing cells using warm medium instead of cold medium is ex-uptake of arachidonic acid in whole cells was determined by incu-
tremely critical to the reduction of the background. This washingbating 1.5 3 105 cells/60 mm tissueculture dish with 10 mM arachido-
step explains the much higher increase in peroxides than reportednate plus 5 mCi/ml [3H] arachidonate for 1 hr at various times after
previously (Maher and Davis, 1996). Viable cells (10,000) were sub-adding glutamate. The culture medium and cells were then collected
jected to FACScan (Becton Dickinson) with excitation set at 488 nmand assayed for radioactivity.
and emission at 525 nm.
GSH Measurement
ReagentsCellular GSH content was determinedby the method of Tietze (1969).
Tissue culture reagents were purchased from GIBCO (Grand Island,HT22 cells (5 3 105) or 8 3 106 primary cortical neurons were col-
NY), and the minimal essential medium used for cortical neuronslected in 125 ml phosphate-buffered saline, and 62 ml 10% sulfosali-
was from Sigma (St. Louis). The fluorescence dyes 29,79-dichloroflu-cylic acid was added. After 15 min on ice, the solution was centri-
orescin diacetate and indo-1 acetoxymethylester (indo-1) were fromfuged, and the supernatant was added to 25 ml 50% triethanolamine.
Molecular Probes (Eugene, OR). 5, 8, 11, 14-ETYA was from LCThe GSH content was assayed in a 96-well microtiter plate as fol-
Laboratories (Woburn, MA). AA861, baicalein, CDC, and DAA werelows: 50 ml samples or standards were placed in each well and then
from Biomol (Plymouth, PA). Arachidonic acid, DL-BSO, caffeic acid,50 ml 1.5 mM 5, 59-dithiobis-2-nitrobenzoic acid and 50 ml solution
GSH, indomethcain, metyrapone, MTT, and NDGA were from Sigma.containing 0.6 mg/ml NADPH and 8.3 U/ml GSH reductase were
sequentially added. Reaction kinetics were determined by repeat-
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